how much weight loss first week tirzepatide Study Shows Lowers Across All Groups With Obesity Can Tirzepatide Help You Lose

Obesity is widespread in the U.S., affecting 42.4% of adults (over 140 million Americans), with 9.2% classified as severely obese (over 30 million Americans)

Often referred to as an eye stroke, NAION is a rare but serious condition where blood flow to the optic nerve is suddenly reduced, leading to painless and irreversible vision loss

Until the FDA issues specific guidance defining the comparability standard for autologous C&G therapies (a process that will require substantial scientific input from industry, academia, and patient advocacy groups), the BPCIA pathway for C&G therapy biosimilars remains operationally undefined

51.4% of Patients Would Consider Using GLP-1 Drugs Again 51.4% of participants said they would use GLP-1s again

Does the anxiety go away as my body adjusts